{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:53:26Z","timestamp":1790679206242,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,7,23]],"date-time":"2018-07-23T00:00:00Z","timestamp":1532304000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 475-2016"],"award-info":[{"award-number":["ALTF 475-2016"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004410","name":"European Molecular Biology Organization","doi-asserted-by":"publisher","award":["ALTF 475-2016"],"award-info":[{"award-number":["ALTF 475-2016"]}],"id":[{"id":"10.13039\/100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fabry disease is a lysosomal storage disorder resulting from impaired alpha-galactosidase A (\u03b1-Gal A) enzyme activity due to mutations in the <jats:italic>GLA<\/jats:italic> gene. Currently, powerful diagnostic tools and <jats:italic>in vivo<\/jats:italic> research models to study Fabry disease are missing, which is a major obstacle for further improvements in diagnosis and therapy. Here, we explore the utility of urine-derived primary cells of Fabry disease patients. Viable cells were isolated and cultured from fresh urine void. The obtained cell culture, modeling the renal epithelium, is characterized by patient-specific information. We demonstrate that this non-invasive source of patient cells provides an adequate cellular <jats:italic>in vivo<\/jats:italic> model as cells exhibit decreased \u03b1-Gal A enzyme activity and concomitant globotriaosylceramide accumulation. Subsequent quantitative proteomic analyses revealed dysregulation of endosomal and lysosomal proteins indicating an involvement of the Coordinated Lysosomal Expression and Regulation (CLEAR) network in the disease pathology. This proteomic pattern resembled data from our previously described human podocyte model of Fabry disease. Taken together, the employment of urine-derived primary cells of Fabry disease patients might have diagnostic and prognostic implications in the future. Our findings pave the way towards a more detailed understanding of pathophysiological mechanisms and may allow the development of future tailored therapeutic strategies.<\/jats:p>","DOI":"10.1038\/s41598-018-29240-w","type":"journal-article","created":{"date-parts":[[2018,7,17]],"date-time":"2018-07-17T09:34:35Z","timestamp":1531820075000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Urine-derived cells: a promising diagnostic tool in Fabry disease patients"],"prefix":"10.1038","volume":"8","author":[{"given":"Gisela G.","family":"Slaats","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Hoehne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Blomberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Benzing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5194-9000","authenticated-orcid":false,"given":"Bernhard","family":"Schermer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M.","family":"Rinschen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine E.","family":"Kurschat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,7,23]]},"reference":[{"key":"29240_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/B978-0-444-62702-5.00017-2","volume":"132","author":"R Schiffmann","year":"2015","unstructured":"Schiffmann, R. Fabry disease. Handb Clin Neurol 132, 231\u2013248 (2015).","journal-title":"Handb Clin Neurol"},{"key":"29240_CR2","first-page":"2168","volume":"25","author":"AB Fogo","year":"2010","unstructured":"Fogo, A. B. et al. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN). 25, 2168\u20132177 (2010).","journal-title":"in"},{"key":"29240_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJM200107053450102","volume":"345","author":"CM Eng","year":"2001","unstructured":"Eng, C. M. et al. Safety and efficacy of recombinant human alpha-galactosidase A\u2013replacement therapy in Fabry\u2019s disease. N. Engl. J. Med. 345, 9\u201316 (2001).","journal-title":"N. Engl. J. Med."},{"key":"29240_CR4","doi-asserted-by":"publisher","first-page":"2743","DOI":"10.1001\/jama.285.21.2743","volume":"285","author":"R Schiffmann","year":"2001","unstructured":"Schiffmann, R. et al. Enzyme replacement therapy in Fabry disease: a randomized controlled trial. JAMA 285, 2743\u20132749 (2001).","journal-title":"JAMA"},{"key":"29240_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymgme.2017.08.004","volume":"122","author":"A Talbot","year":"2017","unstructured":"Talbot, A., Nicholls, K., Fletcher, J. M. & Fuller, M. A simple method for quantification of plasma globotriaosylsphingosine: Utility for Fabry disease. Molecular Genetics and Metabolism 122, 121\u2013125 (2017).","journal-title":"Molecular Genetics and Metabolism"},{"key":"29240_CR6","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ymgme.2017.06.006","volume":"121","author":"A Nowak","year":"2017","unstructured":"Nowak, A., Mechtler, T., Kasper, D. C. & Desnick, R. J. Correlation of Lyso-Gb3 levels in dried blood spots and sera from patients with classic and Later-Onset Fabry disease. Molecular Genetics and Metabolism 121, 320\u2013324 (2017).","journal-title":"Molecular Genetics and Metabolism"},{"key":"29240_CR7","doi-asserted-by":"publisher","first-page":"e0182379","DOI":"10.1371\/journal.pone.0182379","volume":"12","author":"M Arends","year":"2017","unstructured":"Arends, M. et al. Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors. PLoS ONE 12, e0182379 (2017).","journal-title":"PLoS ONE"},{"key":"29240_CR8","doi-asserted-by":"publisher","DOI":"10.1186\/s13630-015-0017-x","volume":"4","author":"H Ajzenberg","year":"2015","unstructured":"Ajzenberg, H. et al. Non-invasive sources of cells with primary cilia from pediatric and adult patients. Cilia 4, 8 (2015).","journal-title":"Cilia"},{"key":"29240_CR9","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1172\/JCI80657","volume":"125","author":"GG Slaats","year":"2015","unstructured":"Slaats, G. G. et al. DNA replication stress underlies renal phenotypes in CEP290-associated Joubert syndrome. J. Clin. Invest. 125, 3657\u20133666 (2015).","journal-title":"J. Clin. Invest."},{"key":"29240_CR10","doi-asserted-by":"publisher","first-page":"9893","DOI":"10.1073\/pnas.1322373111","volume":"111","author":"AM Hynes","year":"2014","unstructured":"Hynes, A. M. et al. Murine Joubert syndrome reveals Hedgehog signaling defects as a potential therapeutic target for nephronophthisis. Proc. Natl. Acad. Sci. USA 111, 9893\u20139898 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29240_CR11","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1038\/nprot.2012.115","volume":"7","author":"T Zhou","year":"2012","unstructured":"Zhou, T. et al. Generation of human induced pluripotent stem cells from urine samples. Nat Protoc 7, 2080\u20132089 (2012).","journal-title":"Nat Protoc"},{"key":"29240_CR12","doi-asserted-by":"publisher","first-page":"589","DOI":"10.4161\/auto.6.5.11943","volume":"6","author":"M Ch\u00e9vrier","year":"2010","unstructured":"Ch\u00e9vrier, M. et al. Autophagosome maturation is impaired in Fabry disease. Autophagy 6, 589\u2013599 (2010).","journal-title":"Autophagy"},{"key":"29240_CR13","doi-asserted-by":"publisher","unstructured":"Liebau, M. C. et al. Dysregulated autophagy contributes to podocyte damage in Fabry\u2019s disease. Journals.plos.org, https:\/\/doi.org\/10.1371\/journal.pone.0063506.s002.","DOI":"10.1371\/journal.pone.0063506.s002"},{"key":"29240_CR14","doi-asserted-by":"publisher","unstructured":"Sanchez-Ni\u00f1o, M. D. et al. Lyso-Gb3 activates Notch1 in human podocytes. Hum. Mol. Genet. ddv291, https:\/\/doi.org\/10.1093\/hmg\/ddv291 (2015).","DOI":"10.1093\/hmg\/ddv291"},{"key":"29240_CR15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1093\/hmg\/ddt052","volume":"22","author":"W Song","year":"2013","unstructured":"Song, W. et al. TFEB regulates lysosomal proteostasis. Hum. Mol. Genet. 22, 1994\u20132009 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"29240_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-13-S16-S12","volume":"13","author":"J Cox","year":"2012","unstructured":"Cox, J. & Mann, M. 1D and 2D annotation enrichment: a statisticalmethod integrating quantitative proteomics withcomplementary high-throughput data. BMC Bioinformatics 13, S12 (2012).","journal-title":"BMC Bioinformatics"},{"key":"29240_CR17","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1373\/clinchem.2004.041418","volume":"51","author":"M Fuller","year":"2005","unstructured":"Fuller, M. et al. Urinary Lipid Profiling for the Identification of Fabry Hemizygotes and Heterozygotes. Clinical Chemistry 51, 688\u2013694 (2005).","journal-title":"Clinical Chemistry"},{"key":"29240_CR18","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.ymgme.2007.10.001","volume":"93","author":"C Auray-Blais","year":"2008","unstructured":"Auray-Blais, C. et al. Urinary globotriaosylceramide excretion correlates with the genotype in children and adults with Fabry disease. Molecular Genetics and Metabolism 93, 331\u2013340 (2008).","journal-title":"Molecular Genetics and Metabolism"},{"key":"29240_CR19","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s00467-008-0846-6","volume":"23","author":"T Kitagawa","year":"2008","unstructured":"Kitagawa, T. et al. Non-invasive high-risk screening for Fabry disease hemizygotes and heterozygotes. Pediatr. Nephrol. 23, 1461\u20131471 (2008).","journal-title":"Pediatr. Nephrol."},{"key":"29240_CR20","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1172\/JCI9711","volume":"105","author":"A Abe","year":"2000","unstructured":"Abe, A. et al. Reduction of globotriaosylceramide in Fabry disease mice by substrate deprivation. J. Clin. Invest. 105, 1563\u20131571 (2000).","journal-title":"J. Clin. Invest."},{"key":"29240_CR21","doi-asserted-by":"crossref","unstructured":"Miller, J. J. et al. Neuropathic pain in a Fabry disease rat model. JCI Insight 3 (2018).","DOI":"10.1172\/jci.insight.99171"},{"key":"29240_CR22","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1093\/hmg\/ddv638","volume":"25","author":"MP Bartram","year":"2016","unstructured":"Bartram, M. P. et al. Three-layered proteomic characterization of a novel ACTN4 mutation unravels its pathogenic potential in FSGS. Hum. Mol. Genet. 25, 1152\u20131164 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"29240_CR23","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1093\/hmg\/ddr306","volume":"20","author":"M Palmieri","year":"2011","unstructured":"Palmieri, M. et al. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20, 3852\u20133866 (2011).","journal-title":"Hum. Mol. Genet."},{"key":"29240_CR24","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1126\/science.1204592","volume":"332","author":"C Settembre","year":"2011","unstructured":"Settembre, C. et al. TFEB links autophagy to lysosomal biogenesis. Science 332, 1429\u20131433 (2011).","journal-title":"Science"},{"key":"29240_CR25","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/emmm.201202176","volume":"5","author":"C Spampanato","year":"2013","unstructured":"Spampanato, C. et al. Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med 5, 691\u2013706 (2013).","journal-title":"EMBO Mol Med"},{"key":"29240_CR26","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1074\/mcp.M114.045609","volume":"14","author":"N Rauniyar","year":"2015","unstructured":"Rauniyar, N. et al. Quantitative Proteomics of Human Fibroblasts with I1061T Mutation in Niemann-Pick C1 (NPC1) Protein Provides Insights into the Disease Pathogenesis. Mol. Cell Proteomics 14, 1734\u20131749 (2015).","journal-title":"Mol. Cell Proteomics"},{"key":"29240_CR27","doi-asserted-by":"publisher","first-page":"3293","DOI":"10.1091\/mbc.e09-10-0879","volume":"21","author":"B Renvois\u00e9","year":"2010","unstructured":"Renvois\u00e9, B. et al. SPG20 protein spartin is recruited to midbodies by ESCRT-III protein Ist1 and participates in cytokinesis. Mol. Biol. Cell 21, 3293\u20133303 (2010).","journal-title":"Mol. Biol. Cell"},{"key":"29240_CR28","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/0092-8674(87)90295-9","volume":"49","author":"S Rothenberger","year":"1987","unstructured":"Rothenberger, S., Iacopetta, B. J. & K\u00fchn, L. C. Endocytosis of the transferrin receptor requires the cytoplasmic domain but not its phosphorylation site. Cell 49, 423\u2013431 (1987).","journal-title":"Cell"},{"key":"29240_CR29","doi-asserted-by":"crossref","first-page":"14763","DOI":"10.1016\/S0021-9258(18)98752-1","volume":"266","author":"LY Sakai","year":"1991","unstructured":"Sakai, L. Y., Keene, D. R., Glanville, R. W. & B\u00e4chinger, H. P. Purification and partial characterization of fibrillin, a cysteine-rich structural component of connective tissue microfibrils. J. Biol. Chem. 266, 14763\u201314770 (1991).","journal-title":"J. Biol. Chem."},{"key":"29240_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0169-328X(94)00268-J","volume":"29","author":"SO Chan","year":"1995","unstructured":"Chan, S. O. & Chiu, F. C. Cloning and developmental expression of human 66 kd neurofilament protein. Brain Res. Mol. Brain Res. 29, 177\u2013184 (1995).","journal-title":"Brain Res. Mol. Brain Res."},{"key":"29240_CR31","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1681\/ASN.2012030316","volume":"24","author":"C T\u00f8ndel","year":"2013","unstructured":"T\u00f8ndel, C. et al. Agalsidase benefits renal histology in young patients with Fabry disease. J. Am. Soc. Nephrol. 24, 137\u2013148 (2013).","journal-title":"J. Am. Soc. Nephrol."},{"key":"29240_CR32","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1021\/ac026117i","volume":"75","author":"J Rappsilber","year":"2003","unstructured":"Rappsilber, J., Ishihama, Y. & Mann, M. Stop and go extraction tips for matrix-assisted laser desorption\/ionization, nanoelectrospray, and LC\/MS sample pretreatment in proteomics. Anal. Chem. 75, 663\u2013670 (2003).","journal-title":"Anal. Chem."},{"key":"29240_CR33","doi-asserted-by":"publisher","unstructured":"Rinschen, M. M. et al. The ubiquitin ligase Ubr4 controls stability of podocin\/MEC-2 supercomplexes. Hum. Mol. Genet., https:\/\/doi.org\/10.1093\/hmg\/ddw016 (2016).","DOI":"10.1093\/hmg\/ddw016"},{"issue":"M111","key":"29240_CR34","first-page":"011015","volume":"10","author":"A Michalski","year":"2011","unstructured":"Michalski, A. et al. Mass spectrometry-based proteomics using Q Exactive, a high-performance benchtop quadrupole Orbitrap mass spectrometer. Mol. Cell Proteomics 10(M111), 011015 (2011).","journal-title":"Mol. Cell Proteomics"},{"key":"29240_CR35","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/nbt.1511","volume":"26","author":"J Cox","year":"2008","unstructured":"Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nature Biotechnology 26, 1367\u20131372 (2008).","journal-title":"Nature Biotechnology"},{"key":"29240_CR36","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1074\/mcp.M113.031591","volume":"13","author":"J Cox","year":"2014","unstructured":"Cox, J. et al. Accurate proteome-wide label-free quantification by delayed normalization and maximal peptide ratio extraction, termed MaxLFQ. Mol. Cell Proteomics 13, 2513\u20132526 (2014).","journal-title":"Mol. Cell Proteomics"},{"key":"29240_CR37","doi-asserted-by":"publisher","first-page":"5116","DOI":"10.1073\/pnas.091062498","volume":"98","author":"VG Tusher","year":"2001","unstructured":"Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116\u20135121 (2001).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"29240_CR38","doi-asserted-by":"publisher","unstructured":"Borgal, L. et al. Jade-1S phosphorylation induced by CK1\u03b1 contributes to cell cycle progression. Cell Cycle 0, https:\/\/doi.org\/10.1080\/15384101.2016.1152429 (2016).","DOI":"10.1080\/15384101.2016.1152429"},{"key":"29240_CR39","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0021-9258(17)38286-8","volume":"253","author":"JW Kusiak","year":"1978","unstructured":"Kusiak, J. W., Quirk, J. M. & Brady, R. O. Purification and properties of the two major isozymes of alpha-galactosidase from human placenta. J. Biol. Chem. 253, 184\u2013190 (1978).","journal-title":"J. Biol. Chem."},{"key":"29240_CR40","doi-asserted-by":"publisher","first-page":"C404","DOI":"10.1152\/ajpcell.00121.2016","volume":"311","author":"MM Rinschen","year":"2016","unstructured":"Rinschen, M. M. et al. Quantitative deep mapping of the cultured podocyte proteome uncovers shifts in proteostatic mechanisms during differentiation. Am. J. Physiol., Cell Physiol. 311, C404\u2013C417 (2016).","journal-title":"Am. J. Physiol., Cell Physiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29240-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29240-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29240-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T07:32:57Z","timestamp":1671607977000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-29240-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,23]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["29240"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-29240-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,23]]},"assertion":[{"value":"5 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"11042"}}